LPA and atherosclerosis: National guidelines recommend Lp(a) testing among patients with FHx of CVD (15, 16); also, according to the dyslipidemia guidelines issued by the European Society of Cardiology/European Atherosclerosis Society in 2019, it is recommended to contemplate the assessment of Lp(a) levels in individuals with moderate and high ASCVD risk (15).